1. Home
  2. MOGO vs CUE Comparison

MOGO vs CUE Comparison

Compare MOGO & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOGO
  • CUE
  • Stock Information
  • Founded
  • MOGO 2003
  • CUE 2014
  • Country
  • MOGO Canada
  • CUE United States
  • Employees
  • MOGO N/A
  • CUE N/A
  • Industry
  • MOGO
  • CUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOGO
  • CUE Health Care
  • Exchange
  • MOGO Nasdaq
  • CUE Nasdaq
  • Market Cap
  • MOGO 48.6M
  • CUE 57.7M
  • IPO Year
  • MOGO N/A
  • CUE 2018
  • Fundamental
  • Price
  • MOGO $1.61
  • CUE $0.75
  • Analyst Decision
  • MOGO Strong Buy
  • CUE Strong Buy
  • Analyst Count
  • MOGO 1
  • CUE 3
  • Target Price
  • MOGO $4.00
  • CUE $3.00
  • AVG Volume (30 Days)
  • MOGO 1.8M
  • CUE 515.6K
  • Earning Date
  • MOGO 08-11-2025
  • CUE 08-13-2025
  • Dividend Yield
  • MOGO N/A
  • CUE N/A
  • EPS Growth
  • MOGO N/A
  • CUE N/A
  • EPS
  • MOGO N/A
  • CUE N/A
  • Revenue
  • MOGO $28,873,274.00
  • CUE $7,991,000.00
  • Revenue This Year
  • MOGO $59.64
  • CUE N/A
  • Revenue Next Year
  • MOGO $5.55
  • CUE $23.84
  • P/E Ratio
  • MOGO N/A
  • CUE N/A
  • Revenue Growth
  • MOGO 0.62
  • CUE 13.83
  • 52 Week Low
  • MOGO $0.74
  • CUE $0.45
  • 52 Week High
  • MOGO $3.83
  • CUE $1.99
  • Technical
  • Relative Strength Index (RSI)
  • MOGO 44.51
  • CUE 45.03
  • Support Level
  • MOGO $1.60
  • CUE $0.84
  • Resistance Level
  • MOGO $2.06
  • CUE $0.90
  • Average True Range (ATR)
  • MOGO 0.11
  • CUE 0.10
  • MACD
  • MOGO -0.07
  • CUE -0.01
  • Stochastic Oscillator
  • MOGO 1.96
  • CUE 15.33

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: